Krystal Biotech Inc (KRYS)
157.68
-4.08
(-2.52%)
USD |
NASDAQ |
May 08, 16:00
157.48
-0.20
(-0.13%)
Pre-Market: 20:00
Krystal Biotech Market Cap: 4.503B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 4.503B |
| May 07, 2024 | 4.620B |
| May 06, 2024 | 4.482B |
| May 03, 2024 | 4.601B |
| May 02, 2024 | 4.576B |
| May 01, 2024 | 4.560B |
| April 30, 2024 | 4.373B |
| April 29, 2024 | 4.512B |
| April 26, 2024 | 4.475B |
| April 25, 2024 | 4.441B |
| April 24, 2024 | 4.537B |
| April 23, 2024 | 4.623B |
| April 22, 2024 | 4.486B |
| April 19, 2024 | 4.523B |
| April 18, 2024 | 4.678B |
| April 17, 2024 | 4.839B |
| April 16, 2024 | 4.852B |
| April 15, 2024 | 4.843B |
| April 12, 2024 | 4.953B |
| April 11, 2024 | 5.133B |
| April 10, 2024 | 5.012B |
| April 09, 2024 | 5.128B |
| April 08, 2024 | 5.147B |
| April 05, 2024 | 5.136B |
| April 04, 2024 | 5.092B |
| Date | Value |
|---|---|
| April 03, 2024 | 5.074B |
| April 02, 2024 | 5.047B |
| April 01, 2024 | 5.023B |
| March 28, 2024 | 5.074B |
| March 27, 2024 | 5.053B |
| March 26, 2024 | 4.966B |
| March 25, 2024 | 4.832B |
| March 22, 2024 | 4.733B |
| March 21, 2024 | 4.804B |
| March 20, 2024 | 4.847B |
| March 19, 2024 | 4.725B |
| March 18, 2024 | 4.768B |
| March 15, 2024 | 4.894B |
| March 14, 2024 | 4.862B |
| March 13, 2024 | 5.074B |
| March 12, 2024 | 5.063B |
| March 11, 2024 | 4.821B |
| March 08, 2024 | 4.862B |
| March 07, 2024 | 4.795B |
| March 06, 2024 | 4.933B |
| March 05, 2024 | 4.834B |
| March 04, 2024 | 4.525B |
| March 01, 2024 | 4.748B |
| February 29, 2024 | 4.512B |
| February 28, 2024 | 4.614B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
392.87M
Minimum
Jun 14 2019
5.147B
Maximum
Apr 08 2024
1.770B
Average
1.536B
Median
Jun 02 2022
Market Cap Benchmarks
| Axsome Therapeutics Inc | 3.594B |
| Alnylam Pharmaceuticals Inc | 19.26B |
| Catalyst Pharmaceuticals Inc | 1.735B |
| Ionis Pharmaceuticals Inc | 5.862B |
| Madrigal Pharmaceuticals Inc | 4.139B |
Market Cap Related Metrics
| PE Ratio | 83.87 |
| Price to Book Value | 5.634 |
| Price | 157.68 |
| Earnings Yield | 1.19% |